Molecule Details
InChIKeyBXLWVAKSQMYQKF-HRUVVLKGSA-N
Compound Namerac-(2R,3R)-N-(4-(1H-pyrazol-1-yl)benzyl)-4-(2-(3-chlorophenyl)pyrrolidin-1-yl)-2,3-dihydroxy-4-oxobutanamide
Canonical SMILESO=C(NCc1ccc(-n2cccn2)cc1)[C@H](O)[C@@H](O)C(=O)N1CCCC1c1cccc(Cl)c1
Clinical Status Clinical Multi-Target
Targets (Human+Pathogen)5
Pfam Stratification Cross-Family
Avg pChEMBL7.08
SourceChEMBL;BindingDB;TTD_MultiTarget
2D Structure
2D structure
Activity Profile
Target Activities (5)
Target Gene Organism Category Pfam pChEMBL Type Source
P78536 ADAM17 Homo sapiens Human PF16698 PF00200 PF13574 8.4 Ki ChEMBL;BindingDB
P08253 MMP2 Homo sapiens Human PF00040 PF00045 PF00413 6.9 pIC50 TTD_MultiTarget
P50281 MMP14 Homo sapiens Human PF11857 PF00045 PF00413 PF01471 6.9 Ki ChEMBL;BindingDB
O14672 ADAM10 Homo sapiens Human PF21299 PF00200 PF13574 6.2 Ki ChEMBL;BindingDB
P18843 nadE Escherichia coli (strain K12) Pathogen PF02540 6.9 pIC50 TTD_MultiTarget